Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
59.90
-0.59 (-0.98%)
Oct 30, 2026, 4:00 PM EST - Market closed
Arrowhead Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Buy Initiates $109 | Buy | Initiates | $109 | +81.97% | Oct 21, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $126 | Buy | Reiterates | $126 | +110.35% | Oct 15, 2026 |
| Citi | Citi | Buy Maintains $108 | Buy | Maintains | $108 | +80.30% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +100.33% | Oct 14, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $100 | Buy | Maintains | $100 | +66.94% | Oct 12, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $74 | Hold | Initiates | $74 | +23.54% | Sep 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $120 | Buy | Reiterates | $120 | +100.33% | Sep 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.